CMS Holds the Line: What the Latest Skin Substitute Policy Changes Mean for the Birth Tissue Industry
The reimbursement landscape for skin substitutes and birth tissue products continues to evolve, and the latest updates from...
Focusing on innovation, collaboration, and the transformative potential of birth tissue-derived products in healthcare.
Be part of the future of regenerative medicine—for free. The American Amnion Association is building a strong, united voice to drive real change in medicine, regulation, insurance, and law. By growing our membership, we can influence policies, establish industry standards, and advocate for birth tissue-derived products to become a standard of care. Your membership strengthens this movement, ensuring that these life-changing innovations reach more patients safely and effectively. Join today and help shape the future of medicine!
- Dedicated to fostering research, education, and collaboration among industry professionals, healthcare providers, and regulatory bodies.
- Our primary objective is to establish strong, collaborative relationships with regulatory bodies, medical boards, insurance providers, and policymakers in order to support and advance responsible regulation
– Informing patients about the benefits, risks, and ethical considerations of amniotic therapies.
The American Amnion Association is dedicated to advancing the understanding, development, and utilization of birth tissue-derived medical innovations. Our mission is to foster research, support clinical applications, and promote education about the therapeutic benefits of amniotic products. We are committed to bridging the gap between innovative research and practical medical applications, ensuring that these products are used safely and effectively to enhance patient care and treatment outcomes.
The American Amnion Association is committed to the highest ethical standards in regenerative medicine.
Our goal is to collaborate with regulatory and governing bodies to uphold compliance and work together.
Supporting peer-reviewed studies and clear, evidence-based clinical guidance.
Working toward the goal of making birth tissue-derived products as standard-of-care.
Our vision is a future where birth tissue-derived medicine is an integral and accessible component of regenerative medicine and therapeutic treatments. We aspire to be at the forefront of advocating for and supporting advancements in this field. By collaborating with healthcare professionals, researchers, and policy makers, we aim to establish comprehensive standards, elevate public and professional awareness, and contribute to the development of treatments that can significantly improve — and potentially save — patient lives.
We support and promote cutting-edge research on birth tissue-derived medicine to drive innovation in regenerative healthcare.
We provide guidance on the safe and effective use of amniotic products to enhance patient outcomes in medical treatments.
We educate healthcare professionals, policymakers, and the public on the benefits, safety, and science behind amniotic therapies.
We advocate for responsible practices, regulatory standards, and ethical guidelines to ensure patient safety and product integrity.
We collaborate with lawmakers and industry leaders to shape policies that support the responsible growth of amniotic medicine.
We connect researchers, clinicians, and industry experts to drive innovation and expand the impact of birth tissue-derived therapies.
Join the American Amnion Association and become part of the movement shaping the future of amniotic-based regenerative medicine. Whether you are a clinician, researcher, industry professional, or patient advocate, your involvement is crucial in advancing the science and ethical application of these therapies.
Access research, training, and certification programs.
Collaborate on studies and innovation in regenerative medicine.
Ensure compliance and quality standards in product development.
Learn about treatment options and ethical considerations.
If you’ve got an amazing story to share, please reach out to us and share with the community. And, if you’re not shy about it, check in with us and be a guest on our podcast.
As a surgeon, my priority is providing patients with the best possible care. Amniotic membrane patches have been a game-changer in many of my surgical procedures. The American Amnion Association is instrumental in advancing education and access to these therapies, ensuring both doctors and patients stay informed about their benefits.
As a birth tissue donation manager, I know amniotic tissue research holds immense potential for regenerative medicine, and the American Amnion Association is playing a crucial role in fostering collaboration between researchers, clinicians, and industry leaders. Their commitment to ethical practices and scientific advancement has helped accelerate innovation, bringing new possibilities for healing to the forefront of medicine.
Our goal for The American Amnion Association is that it becomes the trusted resource in shaping responsible policies around birth tissue-derived products. Their advocacy for transparent regulation and patient access ensures that these promising therapies remain safe, ethical, and available for those who need them most. This work is vital in bridging the gap between science, industry, and government.
After struggling with a torn labrium for months and considering shoulder surgery, I was introduced to amniotic treatment. The results were life-changing. I experienced faster healing and less pain than I ever thought possible, all without surgery. The American Amnion Association helped me understand my options and connected me with valuable resources. I am so grateful for their dedication to patients like me.
Stay informed with the latest in regenerative medicine through our blog, where we cover cutting-edge advancements in amniotic products, groundbreaking medical research, and emerging trends in patient care. We also provide expert insights on regulatory updates, insurance challenges, and the evolving healthcare landscape, ensuring you have the knowledge to navigate this dynamic field. Whether you’re a clinician, researcher, or patient advocate, our blog delivers timely and relevant content to keep you ahead of the curve.
The reimbursement landscape for skin substitutes and birth tissue products continues to evolve, and the latest updates from...
Last year and rapidly moving into 2026, the conversation around skin substitutes, CPTs and HCT/Ps has been lively...
March is National Endometriosis Awareness Month, a time dedicated to shining light on a disease that has affected...
Subscribe to our monthly newsletter and get the latest updates on amniotic research, clinical advancements, regulatory developments, and industry news—straight to your inbox. Join a growing community of professionals and advocates working to shape the future of regenerative medicine. Sign up today and stay at the forefront of innovation!